Moderna is advancing an advanced vaccine candidate through a strategic collaboration with CEPI, requiring Health Canada authorization.
4 reports, 1 independent
Updated Aug 4
Gone quiet
Reached 4 outlets in its first 24 hours
- Reports
- 4
- Developments
- 2
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Moderna is advancing an advanced vaccine candidate through a strategic collaboration with CEPI, requiring Health Canada authorization.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Moderna's vaccine trials received funding from CEPI and authorization from Health Canada, with FDA oversight.Sub-event
Moderna and CEPI collaboration requires Health Canada authorization for advanced vaccine study.1 source
Keep exploring
The entities involved
-
Moderna
American biotechnology company
-
Health Canada
Department of the Canadian Government that oversees public health
-
Coalition for Epidemic Preparedness Innovations
Public-private organization for vaccine development
Nothing else this week.
Related events
- Moderna and Merck are developing cancer vaccines in partnership, while Moderna is also seeking approval for its seasonal influenza vaccine.
- Moderna, Merck, and Georgetown Lombardi Comprehensive Cancer Center are collaborating on developing a personalized cancer vaccine combination.
- Dean Allison criticized Health Canada regarding its handling of vaccine injuries.
- North Carolina donated funds to support the development of Moderna's vaccine.
- Trump administration pushes vaccine approval while FDA moves forward with Moderna vaccine, with Fauci noting incomplete protection.